Symmetry Medical, Inc. (SMA) Reports Q2 Loss of $0.16

Symmetry Medical, Inc. (NYSE: SMA) reported Q2 EPS of ($0.16). Revenue for the quarter came in at $66.82 million.

For earnings history and earnings-related data on Symmetry Medical, Inc. (SMA) click here.

You May Also Be Interested In

• Nscale targets up to $3B in US IPO as soon as September - Bloomberg
• Silexion Therapeutics faces Nasdaq delisting over equity shortfall
• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics